VEGFA and POEMS syndrome: Moreover, four case studies encompassing a cohort of 12 patients, who received bortezomib either as a standalone therapeutic agent or in conjunction with dexamethasone or cyclophosphamide for the management of POEMS syndrome, have demonstrated variable alterations in hemogram parameters, VEGF levels, and mitigation of peripheral nerve symptoms (14).